Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Lipids in Health and Disease

Figure 1

From: Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes

Figure 1

Effect of palmitoleic acid on plasma glucose concentrations in KK-Ay mice. Animals were orally administered vehicle (control), 300 mg/kg of palmitic acid, or 300 mg/kg palmitoleic acid on a daily basis for 4 weeks. Values are means ± SE, n = 10. *p < 0.05 compared with the control group. C16:0, palmitic acid; C16:1, palmitoleic acid.

Back to article page